Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stents | 77 | 2023 | 878 | 9.180 |
Why?
|
Aortic Aneurysm, Abdominal | 46 | 2024 | 452 | 8.460 |
Why?
|
Transcatheter Aortic Valve Replacement | 19 | 2024 | 201 | 8.450 |
Why?
|
Blood Vessel Prosthesis Implantation | 52 | 2024 | 808 | 8.200 |
Why?
|
Endovascular Procedures | 36 | 2024 | 745 | 8.020 |
Why?
|
Aortic Valve Stenosis | 17 | 2024 | 335 | 7.220 |
Why?
|
Blood Vessel Prosthesis | 38 | 2020 | 548 | 7.130 |
Why?
|
Heart Valve Prosthesis Implantation | 12 | 2022 | 436 | 5.060 |
Why?
|
Heart Valve Prosthesis | 17 | 2022 | 301 | 4.960 |
Why?
|
Treatment Outcome | 109 | 2024 | 12289 | 4.530 |
Why?
|
Percutaneous Coronary Intervention | 8 | 2023 | 238 | 4.340 |
Why?
|
Aortic Valve | 18 | 2024 | 444 | 3.970 |
Why?
|
Angioplasty, Balloon | 19 | 2017 | 168 | 3.340 |
Why?
|
Vascular Closure Devices | 8 | 2024 | 14 | 3.220 |
Why?
|
Prosthesis Design | 32 | 2023 | 681 | 2.510 |
Why?
|
Femoral Artery | 21 | 2021 | 194 | 2.480 |
Why?
|
Pulmonary Valve | 4 | 2020 | 92 | 2.330 |
Why?
|
Coronary Artery Disease | 7 | 2023 | 771 | 2.320 |
Why?
|
Hemostatic Techniques | 8 | 2024 | 32 | 2.300 |
Why?
|
Carotid Stenosis | 11 | 2018 | 140 | 2.230 |
Why?
|
Aortic Aneurysm, Thoracic | 10 | 2024 | 670 | 2.010 |
Why?
|
Catheterization, Peripheral | 7 | 2024 | 125 | 1.930 |
Why?
|
Aorta, Abdominal | 8 | 2018 | 124 | 1.920 |
Why?
|
Angioplasty | 8 | 2018 | 87 | 1.880 |
Why?
|
Mitral Valve Insufficiency | 3 | 2022 | 158 | 1.880 |
Why?
|
Humans | 183 | 2024 | 124240 | 1.830 |
Why?
|
Aortic Aneurysm | 4 | 2020 | 235 | 1.790 |
Why?
|
Patient Discharge | 4 | 2019 | 485 | 1.760 |
Why?
|
Cardiac Catheterization | 15 | 2022 | 631 | 1.710 |
Why?
|
Arterial Occlusive Diseases | 11 | 2016 | 134 | 1.630 |
Why?
|
Aneurysm | 8 | 2018 | 91 | 1.570 |
Why?
|
Mitral Valve | 10 | 2023 | 248 | 1.510 |
Why?
|
Aortography | 20 | 2019 | 199 | 1.490 |
Why?
|
Peripheral Arterial Disease | 5 | 2020 | 283 | 1.440 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 16 | 1.380 |
Why?
|
Aortic Diseases | 3 | 2020 | 198 | 1.310 |
Why?
|
Aortic Coarctation | 4 | 2017 | 109 | 1.310 |
Why?
|
Aneurysm, False | 4 | 2018 | 105 | 1.290 |
Why?
|
Time Factors | 31 | 2024 | 6283 | 1.260 |
Why?
|
Suture Techniques | 7 | 2024 | 196 | 1.260 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 142 | 1.220 |
Why?
|
Bioprosthesis | 3 | 2021 | 113 | 1.220 |
Why?
|
Artificial Intelligence | 2 | 2022 | 240 | 1.220 |
Why?
|
Conscious Sedation | 3 | 2021 | 62 | 1.190 |
Why?
|
Popliteal Artery | 6 | 2016 | 54 | 1.180 |
Why?
|
Stroke | 5 | 2021 | 975 | 1.160 |
Why?
|
Aged | 73 | 2024 | 19537 | 1.150 |
Why?
|
Endoleak | 4 | 2019 | 45 | 1.130 |
Why?
|
Length of Stay | 7 | 2021 | 1303 | 1.120 |
Why?
|
Thrombectomy | 6 | 2020 | 107 | 1.120 |
Why?
|
Aorta, Thoracic | 4 | 2020 | 528 | 1.090 |
Why?
|
Punctures | 7 | 2024 | 55 | 1.050 |
Why?
|
Aged, 80 and over | 33 | 2024 | 6464 | 1.040 |
Why?
|
Peripheral Vascular Diseases | 5 | 2011 | 92 | 1.030 |
Why?
|
Hemorrhage | 5 | 2024 | 467 | 1.020 |
Why?
|
Anesthesia, Local | 2 | 2019 | 48 | 1.010 |
Why?
|
Vascular Surgical Procedures | 9 | 2013 | 575 | 0.980 |
Why?
|
Heart Septum | 5 | 2021 | 54 | 0.960 |
Why?
|
Thrombosis | 6 | 2018 | 520 | 0.940 |
Why?
|
Iliac Artery | 7 | 2003 | 93 | 0.860 |
Why?
|
Academies and Institutes | 2 | 2023 | 83 | 0.860 |
Why?
|
Registries | 8 | 2020 | 1421 | 0.860 |
Why?
|
Endarterectomy, Carotid | 5 | 2018 | 99 | 0.850 |
Why?
|
Tomography, X-Ray Computed | 19 | 2016 | 2089 | 0.840 |
Why?
|
Embolization, Therapeutic | 4 | 2017 | 224 | 0.830 |
Why?
|
Vascular Fistula | 2 | 2018 | 30 | 0.800 |
Why?
|
Machine Learning | 2 | 2022 | 242 | 0.790 |
Why?
|
Absorbable Implants | 2 | 2023 | 23 | 0.790 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2022 | 63 | 0.780 |
Why?
|
Triiodobenzoic Acids | 1 | 2022 | 28 | 0.770 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 515 | 0.760 |
Why?
|
Atherectomy, Coronary | 2 | 2021 | 9 | 0.740 |
Why?
|
Male | 84 | 2024 | 61023 | 0.730 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2021 | 16 | 0.720 |
Why?
|
Risk Factors | 21 | 2024 | 10248 | 0.710 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 1112 | 0.710 |
Why?
|
Prospective Studies | 17 | 2024 | 6118 | 0.700 |
Why?
|
Prostheses and Implants | 2 | 2020 | 151 | 0.700 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2017 | 171 | 0.700 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 169 | 0.700 |
Why?
|
Coronary Occlusion | 1 | 2020 | 27 | 0.690 |
Why?
|
Vascular Calcification | 1 | 2021 | 56 | 0.680 |
Why?
|
Hemostatics | 1 | 2020 | 57 | 0.670 |
Why?
|
Pulmonary Artery | 3 | 2020 | 440 | 0.670 |
Why?
|
Renal Artery | 2 | 2016 | 75 | 0.670 |
Why?
|
Minimally Invasive Surgical Procedures | 3 | 2019 | 200 | 0.670 |
Why?
|
Contrast Media | 2 | 2022 | 470 | 0.660 |
Why?
|
Hemostasis | 1 | 2020 | 69 | 0.660 |
Why?
|
Middle Aged | 64 | 2024 | 26601 | 0.660 |
Why?
|
Cryotherapy | 2 | 2011 | 22 | 0.650 |
Why?
|
Stenosis, Pulmonary Artery | 1 | 2019 | 5 | 0.640 |
Why?
|
Postoperative Complications | 14 | 2018 | 3065 | 0.630 |
Why?
|
Transplant Recipients | 1 | 2021 | 216 | 0.630 |
Why?
|
Vascular System Injuries | 1 | 2020 | 54 | 0.630 |
Why?
|
Female | 79 | 2024 | 66304 | 0.630 |
Why?
|
Carotid Artery, Common | 5 | 2007 | 73 | 0.630 |
Why?
|
Coronary Restenosis | 2 | 2017 | 19 | 0.620 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2020 | 101 | 0.620 |
Why?
|
Graft Occlusion, Vascular | 5 | 2020 | 101 | 0.610 |
Why?
|
Heart | 3 | 2023 | 708 | 0.610 |
Why?
|
Septal Occluder Device | 1 | 2019 | 42 | 0.600 |
Why?
|
Leadership | 1 | 2021 | 227 | 0.600 |
Why?
|
Equipment Design | 11 | 2024 | 587 | 0.600 |
Why?
|
Follow-Up Studies | 30 | 2019 | 5129 | 0.600 |
Why?
|
Aortic Rupture | 2 | 2018 | 120 | 0.600 |
Why?
|
Retrospective Studies | 30 | 2021 | 16293 | 0.590 |
Why?
|
Hospital Costs | 1 | 2019 | 178 | 0.590 |
Why?
|
Vascular Patency | 8 | 2020 | 214 | 0.580 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2019 | 118 | 0.580 |
Why?
|
Periodicals as Topic | 1 | 2021 | 198 | 0.580 |
Why?
|
Vena Cava, Inferior | 1 | 2018 | 103 | 0.580 |
Why?
|
Prosthesis Failure | 6 | 2012 | 158 | 0.570 |
Why?
|
Hospitals, Teaching | 1 | 2018 | 105 | 0.570 |
Why?
|
Radiography | 14 | 2016 | 821 | 0.560 |
Why?
|
Lasers | 1 | 2017 | 114 | 0.550 |
Why?
|
Atrial Appendage | 1 | 2017 | 46 | 0.550 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 55 | 0.550 |
Why?
|
Aspirin | 1 | 2018 | 224 | 0.530 |
Why?
|
Lung Diseases | 1 | 2020 | 384 | 0.530 |
Why?
|
Norwood Procedures | 1 | 2017 | 101 | 0.520 |
Why?
|
Women's Health | 1 | 2017 | 133 | 0.520 |
Why?
|
Internship and Residency | 2 | 2021 | 1180 | 0.520 |
Why?
|
Thoracic Surgical Procedures | 1 | 2017 | 90 | 0.510 |
Why?
|
Equipment Failure | 3 | 2008 | 122 | 0.500 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2016 | 42 | 0.490 |
Why?
|
Algorithms | 2 | 2022 | 1606 | 0.490 |
Why?
|
Cardiology | 1 | 2021 | 503 | 0.480 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 84 | 0.480 |
Why?
|
Heart-Assist Devices | 2 | 2021 | 1036 | 0.480 |
Why?
|
Feasibility Studies | 6 | 2018 | 747 | 0.480 |
Why?
|
Vascular Malformations | 1 | 2016 | 88 | 0.480 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2017 | 144 | 0.470 |
Why?
|
Lower Extremity | 3 | 2016 | 180 | 0.470 |
Why?
|
Vascular Access Devices | 2 | 2015 | 35 | 0.470 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 727 | 0.460 |
Why?
|
Cardiomyopathies | 1 | 2019 | 494 | 0.450 |
Why?
|
Texas | 12 | 2011 | 3578 | 0.440 |
Why?
|
Renal Artery Obstruction | 2 | 2008 | 41 | 0.440 |
Why?
|
Hospitals, High-Volume | 1 | 2014 | 35 | 0.440 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2020 | 262 | 0.430 |
Why?
|
Myocardial Infarction | 3 | 2020 | 1010 | 0.430 |
Why?
|
Risk Assessment | 10 | 2021 | 3431 | 0.420 |
Why?
|
Renal Dialysis | 1 | 2020 | 848 | 0.420 |
Why?
|
Angiography | 10 | 2016 | 215 | 0.400 |
Why?
|
Inpatients | 1 | 2016 | 492 | 0.400 |
Why?
|
Ultrasonography, Interventional | 2 | 2015 | 192 | 0.400 |
Why?
|
Surgical Wound Infection | 2 | 2006 | 259 | 0.390 |
Why?
|
Research Design | 2 | 2015 | 689 | 0.390 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 436 | 0.390 |
Why?
|
United States | 8 | 2021 | 10868 | 0.390 |
Why?
|
Tricuspid Valve | 2 | 2022 | 59 | 0.370 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2011 | 20 | 0.360 |
Why?
|
Reoperation | 7 | 2012 | 831 | 0.360 |
Why?
|
Intracranial Embolism | 1 | 2010 | 27 | 0.350 |
Why?
|
Forecasting | 2 | 2022 | 350 | 0.350 |
Why?
|
Metals | 2 | 2020 | 61 | 0.350 |
Why?
|
Catheters | 1 | 2010 | 87 | 0.340 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 659 | 0.340 |
Why?
|
Iliac Vein | 1 | 2010 | 34 | 0.330 |
Why?
|
Foreign-Body Migration | 1 | 2010 | 72 | 0.320 |
Why?
|
Sutures | 2 | 2020 | 65 | 0.320 |
Why?
|
Incidence | 5 | 2022 | 3135 | 0.320 |
Why?
|
Embolism | 1 | 2009 | 48 | 0.310 |
Why?
|
Recurrence | 9 | 2008 | 1421 | 0.300 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 2006 | 40 | 0.290 |
Why?
|
Hemodynamics | 7 | 2020 | 850 | 0.280 |
Why?
|
Carotid Artery Diseases | 2 | 2006 | 147 | 0.280 |
Why?
|
Operative Time | 2 | 2019 | 171 | 0.280 |
Why?
|
Computed Tomography Angiography | 2 | 2019 | 198 | 0.270 |
Why?
|
Heart Arrest | 1 | 2011 | 351 | 0.270 |
Why?
|
Congresses as Topic | 2 | 2017 | 174 | 0.260 |
Why?
|
Stroke Volume | 6 | 2019 | 486 | 0.260 |
Why?
|
Anesthesia, General | 2 | 2018 | 118 | 0.260 |
Why?
|
Thrombolytic Therapy | 3 | 2011 | 208 | 0.260 |
Why?
|
Carotid Artery Injuries | 1 | 2006 | 40 | 0.260 |
Why?
|
Coronary Disease | 8 | 2001 | 672 | 0.250 |
Why?
|
Cardiomyopathy, Hypertrophic | 7 | 1989 | 156 | 0.250 |
Why?
|
Aorta | 3 | 2020 | 537 | 0.250 |
Why?
|
Celiac Artery | 1 | 2006 | 33 | 0.250 |
Why?
|
Arteriovenous Fistula | 1 | 2006 | 57 | 0.250 |
Why?
|
Echocardiography, Transesophageal | 3 | 2017 | 240 | 0.250 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 509 | 0.240 |
Why?
|
Program Evaluation | 2 | 2018 | 442 | 0.240 |
Why?
|
Elective Surgical Procedures | 2 | 2016 | 159 | 0.240 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2004 | 9 | 0.230 |
Why?
|
Polytetrafluoroethylene | 4 | 2010 | 84 | 0.230 |
Why?
|
Fibrinolytic Agents | 1 | 2006 | 202 | 0.220 |
Why?
|
Catheters, Indwelling | 2 | 2002 | 154 | 0.210 |
Why?
|
Coronary Angiography | 7 | 2020 | 425 | 0.210 |
Why?
|
Intestinal Fistula | 1 | 2002 | 28 | 0.200 |
Why?
|
North America | 2 | 2020 | 239 | 0.200 |
Why?
|
Iohexol | 1 | 2022 | 20 | 0.200 |
Why?
|
Adult | 32 | 2019 | 29359 | 0.200 |
Why?
|
Heart Ventricles | 6 | 2021 | 764 | 0.190 |
Why?
|
Credentialing | 1 | 2022 | 18 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2016 | 2883 | 0.190 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 556 | 0.190 |
Why?
|
Survival Rate | 3 | 2018 | 2040 | 0.180 |
Why?
|
Sirolimus | 1 | 2023 | 223 | 0.180 |
Why?
|
Constriction, Pathologic | 3 | 2010 | 242 | 0.180 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 61 | 0.180 |
Why?
|
Patient Selection | 2 | 2017 | 690 | 0.180 |
Why?
|
Phlebography | 2 | 2011 | 50 | 0.170 |
Why?
|
Echocardiography | 7 | 2016 | 1051 | 0.170 |
Why?
|
Comorbidity | 5 | 2015 | 1530 | 0.170 |
Why?
|
Latin America | 1 | 2020 | 92 | 0.170 |
Why?
|
Prosthesis-Related Infections | 1 | 2002 | 177 | 0.170 |
Why?
|
Radial Artery | 1 | 2020 | 28 | 0.170 |
Why?
|
Dissent and Disputes | 1 | 2020 | 32 | 0.170 |
Why?
|
Carotid Arteries | 1 | 2001 | 150 | 0.170 |
Why?
|
Myocardial Reperfusion | 1 | 2020 | 72 | 0.170 |
Why?
|
Arteriovenous Malformations | 1 | 2000 | 47 | 0.170 |
Why?
|
Hope | 1 | 2020 | 13 | 0.170 |
Why?
|
Arm | 1 | 2000 | 81 | 0.170 |
Why?
|
Suction | 2 | 2010 | 56 | 0.170 |
Why?
|
Skull | 1 | 2001 | 142 | 0.160 |
Why?
|
Japan | 1 | 2020 | 133 | 0.160 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 585 | 0.160 |
Why?
|
Fibromuscular Dysplasia | 1 | 1999 | 7 | 0.160 |
Why?
|
Retreatment | 1 | 2019 | 88 | 0.160 |
Why?
|
Patient Readmission | 2 | 2020 | 384 | 0.160 |
Why?
|
Cost Savings | 1 | 2019 | 71 | 0.160 |
Why?
|
Solutions | 1 | 2019 | 65 | 0.160 |
Why?
|
Pilot Projects | 3 | 2010 | 1369 | 0.160 |
Why?
|
Off-Label Use | 1 | 2019 | 28 | 0.160 |
Why?
|
Pennsylvania | 1 | 2018 | 53 | 0.150 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 181 | 0.150 |
Why?
|
Coronary Vessels | 2 | 2022 | 537 | 0.150 |
Why?
|
Radiation Injuries | 1 | 2000 | 143 | 0.150 |
Why?
|
Ticlopidine | 1 | 2018 | 27 | 0.150 |
Why?
|
Arteriosclerosis | 4 | 2005 | 144 | 0.150 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2007 | 50 | 0.150 |
Why?
|
Dimethyl Sulfoxide | 1 | 2017 | 18 | 0.150 |
Why?
|
Polyvinyls | 1 | 2017 | 13 | 0.150 |
Why?
|
Cardiologists | 1 | 2017 | 20 | 0.140 |
Why?
|
Device Removal | 4 | 2002 | 221 | 0.140 |
Why?
|
Dreams | 1 | 2017 | 24 | 0.140 |
Why?
|
Everolimus | 1 | 2017 | 47 | 0.140 |
Why?
|
Fibrosis | 1 | 2019 | 430 | 0.140 |
Why?
|
Creatinine | 1 | 2019 | 389 | 0.140 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2017 | 19 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 1031 | 0.140 |
Why?
|
Adenosine | 1 | 2018 | 127 | 0.140 |
Why?
|
Paclitaxel | 1 | 2017 | 125 | 0.140 |
Why?
|
Heterografts | 1 | 2017 | 171 | 0.130 |
Why?
|
Balloon Valvuloplasty | 1 | 2016 | 25 | 0.130 |
Why?
|
Time Management | 1 | 2016 | 11 | 0.130 |
Why?
|
Ductus Arteriosus | 1 | 2017 | 62 | 0.130 |
Why?
|
Propensity Score | 1 | 2017 | 215 | 0.130 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 53 | 0.130 |
Why?
|
Child | 6 | 2020 | 24361 | 0.130 |
Why?
|
Suture Anchors | 1 | 2015 | 3 | 0.130 |
Why?
|
Saphenous Vein | 2 | 2006 | 60 | 0.130 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2015 | 31 | 0.130 |
Why?
|
Pressure | 1 | 2016 | 117 | 0.130 |
Why?
|
Paraplegia | 1 | 2016 | 94 | 0.120 |
Why?
|
Transposition of Great Vessels | 1 | 2017 | 131 | 0.120 |
Why?
|
Recovery of Function | 1 | 2017 | 439 | 0.120 |
Why?
|
Cineangiography | 1 | 2015 | 17 | 0.120 |
Why?
|
Ischemia | 2 | 2015 | 354 | 0.120 |
Why?
|
Brachiocephalic Trunk | 2 | 2005 | 40 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 1228 | 0.120 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 516 | 0.120 |
Why?
|
Blood Platelets | 1 | 2018 | 327 | 0.120 |
Why?
|
Contraindications | 1 | 2015 | 78 | 0.120 |
Why?
|
Kidney | 1 | 2022 | 1357 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 161 | 0.120 |
Why?
|
Sex Factors | 1 | 2018 | 1277 | 0.110 |
Why?
|
Coronary Artery Bypass | 5 | 2013 | 511 | 0.110 |
Why?
|
Syndrome | 2 | 2010 | 1119 | 0.110 |
Why?
|
Intensive Care Units | 1 | 2018 | 489 | 0.110 |
Why?
|
Iatrogenic Disease | 2 | 2008 | 133 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 230 | 0.110 |
Why?
|
Critical Care | 1 | 2019 | 656 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 3 | 2015 | 51 | 0.110 |
Why?
|
Swine | 1 | 2017 | 1177 | 0.110 |
Why?
|
Calcinosis | 1 | 2015 | 177 | 0.110 |
Why?
|
Heart Aneurysm | 2 | 1992 | 39 | 0.110 |
Why?
|
Pain, Postoperative | 1 | 2016 | 263 | 0.110 |
Why?
|
Intermittent Claudication | 2 | 2003 | 58 | 0.100 |
Why?
|
Health Care Costs | 1 | 2015 | 372 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 1992 | 44 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 579 | 0.100 |
Why?
|
Prevalence | 1 | 2018 | 2445 | 0.090 |
Why?
|
Pericardium | 1 | 1992 | 81 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2011 | 508 | 0.090 |
Why?
|
Interinstitutional Relations | 1 | 2011 | 20 | 0.090 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 40 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2016 | 607 | 0.090 |
Why?
|
Permeability | 1 | 2011 | 119 | 0.090 |
Why?
|
Certification | 1 | 2011 | 67 | 0.090 |
Why?
|
Ultrasonography | 2 | 2008 | 931 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 94 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 367 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2011 | 1422 | 0.080 |
Why?
|
Limb Salvage | 1 | 2011 | 127 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2011 | 218 | 0.080 |
Why?
|
Brachiocephalic Veins | 2 | 2005 | 13 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2011 | 3266 | 0.080 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2009 | 107 | 0.080 |
Why?
|
Hypertension, Renovascular | 1 | 2008 | 29 | 0.070 |
Why?
|
Odds Ratio | 1 | 2011 | 1252 | 0.070 |
Why?
|
Costs and Cost Analysis | 3 | 2019 | 164 | 0.070 |
Why?
|
Pulmonary Edema | 1 | 2008 | 48 | 0.070 |
Why?
|
Collateral Circulation | 2 | 2005 | 45 | 0.070 |
Why?
|
Patient Care Team | 1 | 2011 | 542 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 633 | 0.070 |
Why?
|
Takayasu Arteritis | 2 | 1996 | 13 | 0.070 |
Why?
|
Logistic Models | 1 | 2011 | 1799 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2007 | 171 | 0.060 |
Why?
|
Polyesters | 2 | 2006 | 39 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2006 | 355 | 0.060 |
Why?
|
Wounds, Penetrating | 1 | 2006 | 141 | 0.060 |
Why?
|
Curriculum | 1 | 2011 | 727 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 298 | 0.060 |
Why?
|
Arteries | 1 | 2006 | 221 | 0.060 |
Why?
|
Clinical Competence | 1 | 2011 | 994 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2005 | 168 | 0.050 |
Why?
|
Infant | 1 | 2019 | 12465 | 0.050 |
Why?
|
Cohort Studies | 4 | 2019 | 4779 | 0.050 |
Why?
|
Eikenella corrodens | 1 | 2002 | 4 | 0.050 |
Why?
|
Blood Circulation | 1 | 2002 | 21 | 0.050 |
Why?
|
Fusobacterium Infections | 1 | 2002 | 14 | 0.050 |
Why?
|
Wound Healing | 1 | 2006 | 436 | 0.050 |
Why?
|
Equipment Safety | 1 | 2002 | 36 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2006 | 458 | 0.050 |
Why?
|
Brachial Artery | 2 | 1982 | 39 | 0.050 |
Why?
|
Coronary Vessel Anomalies | 4 | 1980 | 279 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2005 | 357 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2002 | 61 | 0.050 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2001 | 15 | 0.050 |
Why?
|
Subclavian Steal Syndrome | 1 | 2001 | 8 | 0.050 |
Why?
|
Time | 1 | 2001 | 93 | 0.050 |
Why?
|
Subclavian Artery | 1 | 2001 | 74 | 0.040 |
Why?
|
Perioperative Care | 1 | 2002 | 195 | 0.040 |
Why?
|
Anticoagulants | 2 | 2002 | 590 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 243 | 0.040 |
Why?
|
Coronary Circulation | 1 | 2001 | 213 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2001 | 198 | 0.040 |
Why?
|
Rupture | 1 | 1999 | 32 | 0.040 |
Why?
|
Blood Vessels | 1 | 2000 | 102 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2000 | 67 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2002 | 374 | 0.040 |
Why?
|
Cineradiography | 1 | 1998 | 3 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 1998 | 20 | 0.040 |
Why?
|
Fistula | 1 | 1978 | 49 | 0.040 |
Why?
|
Blood Pressure | 1 | 2002 | 1352 | 0.030 |
Why?
|
Survival Analysis | 2 | 2013 | 1491 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1977 | 91 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 1017 | 0.030 |
Why?
|
Animals | 1 | 2017 | 34046 | 0.030 |
Why?
|
Leg | 1 | 1997 | 155 | 0.030 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 1977 | 133 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 1977 | 215 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 2015 | 87 | 0.030 |
Why?
|
Databases, Factual | 1 | 2019 | 1174 | 0.030 |
Why?
|
Echocardiography, Doppler | 2 | 1998 | 171 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 2143 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1996 | 365 | 0.030 |
Why?
|
Counterpulsation | 1 | 1992 | 4 | 0.030 |
Why?
|
Sex Distribution | 1 | 2013 | 302 | 0.020 |
Why?
|
Adolescent | 7 | 2013 | 19253 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 414 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1992 | 106 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 3549 | 0.020 |
Why?
|
Exercise Test | 2 | 1983 | 253 | 0.020 |
Why?
|
Mitral Valve Stenosis | 2 | 1989 | 35 | 0.020 |
Why?
|
Hospital Mortality | 1 | 1996 | 1021 | 0.020 |
Why?
|
Observer Variation | 1 | 2010 | 299 | 0.020 |
Why?
|
Electrocardiography | 5 | 1987 | 971 | 0.020 |
Why?
|
Myocardial Contraction | 2 | 1989 | 265 | 0.020 |
Why?
|
Cardiac Output | 1 | 1989 | 170 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2010 | 236 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1988 | 132 | 0.020 |
Why?
|
Systole | 2 | 2002 | 198 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1987 | 130 | 0.020 |
Why?
|
Laser Therapy | 1 | 1989 | 249 | 0.020 |
Why?
|
Angina Pectoris | 2 | 1985 | 56 | 0.020 |
Why?
|
Life Tables | 1 | 2005 | 28 | 0.020 |
Why?
|
Safety | 1 | 2006 | 219 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 1983 | 149 | 0.020 |
Why?
|
Alloys | 1 | 2005 | 16 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2006 | 283 | 0.010 |
Why?
|
Elasticity | 1 | 2005 | 90 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2861 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 1348 | 0.010 |
Why?
|
Atropine | 1 | 2002 | 31 | 0.010 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2002 | 22 | 0.010 |
Why?
|
Phenylephrine | 1 | 2002 | 38 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2002 | 55 | 0.010 |
Why?
|
Bradycardia | 1 | 2002 | 60 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2005 | 293 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 256 | 0.010 |
Why?
|
Coated Materials, Biocompatible | 1 | 2002 | 42 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2002 | 223 | 0.010 |
Why?
|
Hypotension | 1 | 2002 | 184 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 1981 | 173 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 9000 | 0.010 |
Why?
|
Lutembacher Syndrome | 1 | 1978 | 1 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1999 | 194 | 0.010 |
Why?
|
Warfarin | 1 | 1998 | 119 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 547 | 0.010 |
Why?
|
Heart Failure | 1 | 1989 | 2288 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 1996 | 35 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 1977 | 152 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 4609 | 0.010 |
Why?
|
Catheterization | 1 | 1996 | 234 | 0.010 |
Why?
|
Child, Preschool | 1 | 1989 | 13997 | 0.010 |
Why?
|
Pronation | 1 | 1989 | 3 | 0.010 |
Why?
|
Angiocardiography | 1 | 1987 | 13 | 0.000 |
Why?
|
Dilatation, Pathologic | 1 | 1987 | 92 | 0.000 |
Why?
|
Heart Atria | 1 | 1989 | 315 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1985 | 69 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1985 | 385 | 0.000 |
Why?
|
Transillumination | 1 | 1981 | 4 | 0.000 |
Why?
|
Dilatation | 1 | 1981 | 64 | 0.000 |
Why?
|
Heart Diseases | 1 | 1985 | 489 | 0.000 |
Why?
|
Risk | 1 | 1981 | 754 | 0.000 |
Why?
|
Sinus of Valsalva | 1 | 1979 | 35 | 0.000 |
Why?
|
Hospitalization | 1 | 1985 | 1770 | 0.000 |
Why?
|